Page last updated: 2024-10-20

uracil and Parkinsonian Disorders

uracil has been researched along with Parkinsonian Disorders in 2 studies

2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Safar, MM1
Abdelkader, NF1
Ramadan, E1
Kortam, MA1
Mohamed, AF1
GOMIRATO, G1
HYDEN, H1

Other Studies

2 other studies available for uracil and Parkinsonian Disorders

ArticleYear
Novel mechanistic insights towards the repositioning of alogliptin in Parkinson's disease.
    Life sciences, 2021, Dec-15, Volume: 287

    Topics: Animals; Dimethyl Sulfoxide; Dipeptidyl-Peptidase IV Inhibitors; Drug Repositioning; Glucagon-Like P

2021
A BIOCHEMICAL GLIA ERROR IN THE PARKINSON DISEASE.
    Brain : a journal of neurology, 1963, Volume: 86

    Topics: Adenine; Cytosine; Globus Pallidus; Guanine; Neurochemistry; Neuroglia; Neurons; Nucleic Acids; Park

1963